Advanced Search

    Technical Analysis for CING - Cingulate Inc.

    Grade Last Price % Change Price Change
    D 1.03 0.98% 0.01
    CING closed up 0.98 percent on Friday, March 24, 2023, on 5 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical CING trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Slingshot Bearish Bearish Swing Setup 0.98%
    Bullish Engulfing Bullish 0.98%
    Stochastic Buy Signal Bullish 0.98%
    Wide Bands Range Expansion 0.98%
    Oversold Stochastic Weakness 0.98%
    Narrow Range Bar Range Contraction 13.19%
    Older End-of-Day Signals for CING ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Possible Inside Day about 11 hours ago
    Rose Above 10 DMA about 14 hours ago
    Down 5% about 14 hours ago
    Down 3% about 14 hours ago
    Down 2 % about 14 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators Basic chart:

    Profile

    Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and evaluating additional therapeutic areas where PTR technology may be employed to develop future product candidates.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Pharmaceutical Products Neuroscience Attention Deficit Hyperactivity Disorder Amphetamine Educational Psychology Methylphenidate Adhd Attention Deficit/Hyperactivity Disorder

    Is CING a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 13 Cingulate stock slumps ~15% on commercialization pact for ADHD drug CTx-1301
    Mar 13 Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301
    Mar 10 Cingulate GAAP EPS of -$0.41 misses by $0.04
    Mar 10 Cingulate Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
    Feb 27 Tesla, Amazon, Union Pacific, Woodside Energy, Cingulate: Why These 5 Stocks Drawing Investors' Attention Today
    Feb 24 Why Cingulate Shares Are Trading Higher Today
    Feb 24 Cingulate stock skyrockets after ADHD treatment shows positive trial results
    Feb 24 Cingulate pops ~76% after hours on trial results for its ADHD treatment drug
    Feb 23 Cingulate Announces Positive Top-Line Results from Fed/Fast Study of Lead Asset CTx-1301 for ADHD
    Jan 17 Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
    See more CING news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.14
    52 Week Low 0.664
    Average Volume 1,015,581
    200-Day Moving Average 1.22
    50-Day Moving Average 1.13
    20-Day Moving Average 1.28
    10-Day Moving Average 1.01
    Average True Range 0.17
    RSI 45.36
    ADX 28.46
    +DI 29.40
    -DI 20.22
    Chandelier Exit (Long, 3 ATRs) 1.43
    Chandelier Exit (Short, 3 ATRs) 1.40
    Upper Bollinger Bands 1.89
    Lower Bollinger Band 0.67
    Percent B (%b) 0.3
    BandWidth 95.22
    MACD Line -0.07
    MACD Signal Line -0.02
    MACD Histogram -0.0486
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.21
    Resistance 3 (R3) 1.19 1.11 1.18
    Resistance 2 (R2) 1.11 1.06 1.12 1.17
    Resistance 1 (R1) 1.07 1.04 1.09 1.09 1.16
    Pivot Point 0.99 0.99 1.00 1.00 0.99
    Support 1 (S1) 0.95 0.95 0.97 0.97 0.90
    Support 2 (S2) 0.87 0.92 0.88 0.89
    Support 3 (S3) 0.83 0.87 0.88
    Support 4 (S4) 0.85